home / stock / sigy / sigy quote
Last: | $5.25 |
---|---|
Change Percent: | 100.0% |
Open: | $0 |
Close: | $5.25 |
High: | $0 |
Low: | $0 |
Volume: | 5 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$5.25 | $0 | $5.25 | $0 | $0 | 5 | 07-12-2024 |
$5.25 | $0 | $5.25 | $0 | $0 | 47 | 07-08-2024 |
$5.25 | $0 | $5.25 | $0 | $0 | 50 | 06-17-2024 |
$5.25 | $0 | $5.25 | $0 | $0 | 4 | 06-14-2024 |
$5.25 | $0 | $5.25 | $0 | $0 | 5 | 06-13-2024 |
$5.25 | $0 | $5.25 | $0 | $0 | 2 | 05-17-2024 |
$5.25 | $5.25 | $5.25 | $5.25 | $5.25 | 445 | 05-15-2024 |
$5 | $5 | $5 | $5 | $5 | 525 | 05-07-2024 |
$5.25 | $5.25 | $5.25 | $5.25 | $5.25 | 300 | 05-03-2024 |
$5.25 | $5.25 | $5.25 | $5.25 | $5.25 | 200 | 05-02-2024 |
$5.5 | $5.75 | $5.5 | $5.75 | $5.5 | 400 | 05-01-2024 |
$6 | $6 | $6 | $6 | $6 | 290 | 04-30-2024 |
$6.34 | $0 | $6.34 | $0 | $0 | 10 | 04-29-2024 |
$6.34 | $6.25 | $6.34 | $6.34 | $6.25 | 200 | 04-26-2024 |
$5.75 | $5.75 | $5.75 | $5.75 | $5.75 | 256 | 04-19-2024 |
$5.5 | $5.8 | $5.5 | $5.8 | $5.5 | 383 | 04-18-2024 |
$6.1 | $0 | $6.1 | $0 | $0 | 25 | 04-17-2024 |
$6.1 | $6.1 | $6.1 | $6.1 | $6.1 | 100 | 04-15-2024 |
$6 | $6.25 | $6 | $6.25 | $6 | 200 | 04-12-2024 |
$5.5 | $0 | $5.5 | $0 | $0 | 5 | 04-03-2024 |
News, Short Squeeze, Breakout and More Instantly...
Sigyn Therapeutics Inc Company Name:
SIGY Stock Symbol:
OTCMKTS Market:
Sigyn Therapeutics Inc Website:
Sigyn Therapeutics (OTCQB: SIGY) , a development-stage medical technology company, today announced financial results for the first quarter ended March 31, 2024. During the quarter, the company reported a loss from operations of $629,972, as compared to an operating loss of $521,258 for the compar...
SAN DIEGO, CA - ( NewMediaWire ) - May 15, 2024 - Sigyn Therapeutics, Inc. (“Sigyn” or the “Company”) (OTCQB: SIGY), a development-stage medical technology company, today announced financial results for the first quarter ended March 31, 2024. During the quarter, the C...
Sigyn Therapeutics (OTCQB: SIGY) , a development-stage medical technology company, today announced that it has published an article entitled: “Sigyn Therapy(TM), an Emerging Candidate to Address Endotoxemia, Sepsis and Drug-Resistant Viral & Bacterial Infections.” “Wh...